Modification To Accu-Space Plain Gut Absorbable Seeding Spacers
Source, Brachytherapy, Radionuclide. 510(k) K013964, from Cp Medical (Portland, OR). Product code KXK, class 2.
As of Nov 20, 2026, K013964 is an FDA 510(k) held by Cp Medical, substantially equivalent on Jan 24, 2002 after 52 days, with no recalls tied to it in FDA's recall database.
- Review time: 52 days
- Recalls: 0
- Cited as a predicate by: 3 devices
CP Medical's absorbable seeding spacers are intended to be used to maintain a predetermined space between radionuclide seeds for the introduction of the seeds into the body during brachytherapy procedures. Seeding spacers are indicated for use in soft tissues or organ tissue but should not be used during cardiovascular or neurological procedures.
- Accu-Space Absorbable Seeding SpacersK010621 · Cp Medical · Sep 4, 2001
- Poiint of Care Stranding System, Mode 1004-00K072296 · Theragenics Corp. · Sep 26, 2007
- I-125 Rapid Strand, Model 7000K030594 · Amersham Health · Apr 10, 2003
- Synthetic Absorbable Seeding Spacers Made of Polydioxanone MaterialK021311 · Cp Medical · Jul 13, 2002
- OncoPatchK252296 · Oncopatch, Inc. · Dec 5, 2025
- IsoSphereK242818 · Isoaid, LLC · Jul 15, 2025
- RadianceTx Radionuclide Brachytherapy SourceK223465 · Radiance Therapeutics, Inc. · Jan 11, 2023
- GammaTileK221539 · Gt Medical Technologies · Nov 9, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Dec 3, 2001
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5730
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files